ImmunoChemistry Technologies Newsroom
Check out the latest press releases and newsletters from ImmunoChemistry Technologies. For direct media requests, contact us at email@example.com.
October 29, 2014 – ImmunoChemistry Technologies Sells Patent for its Proprietary Technology
FLIVO®, which detects cell death in living animals, is now on track for further development and use in cancer research.
September 22, 2014 – We’re CELL-elebrating our 20th Anniversary
ImmunoChemistry Technologies will celebrate 20 Years of Solutions all throughout the coming year.
February 25, 2014 – ICT Introduces Two HRP Conjugate Stabilizers
New conjugate stabilizer formulations prolong the shelf-life of conjugated antibodies and reduce non-specific binding during conjugate incubation.
January 21, 2014 – ICT Introduces Two New ELISA Blocking Buffer Formulations
New blocking buffer formulations offer additional choices to perform this crucial immunoassay step.
December 03, 2013 – ImmunoChemistry Technologies Changes Ownership
Biomedical Lab developing proprietary and patented reagents for cancer research is now majority women-owned.
September 19, 2013 – ImmunoChemistry Technologies Celebrates 19th Anniversary
ImmunoChemistry Technologies is now celebrating its 20th Year of Solutions.
New assay introduces a far-red fluorescent option for in vitro apoptosis detection.